Author:
Althunian Turki A.,de Boer Anthonius,Klungel Olaf H.,Insani Widya N.,Groenwold Rolf H. H.
Funder
The Saudi Food and Drug Authority
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference25 articles.
1. Suda KJ, Hurley AM, McKibbin T, Motl Moroney SE. Publication of noninferiority clinical trials: changes over a 20-year interval. Pharmacotherapy. 2011;31(9):833–9.
2. Center for Biologics Evaluation and Research (CBER), Center for Drug Evaluation and Research (CDER). Guidance for Industry Non-Inferiority Clinical Trials. Food and Drug Administration, U.S. Department of Health and Human Services. 2010. http://www.fda.gov/downloads/Drugs/…/Guidances/UCM202140.pdf . Accessed 15 Oct 2014.
3. Mulla SM, Scott IA, Jackevicius CA, You JJ, Guyatt GH. How to use a noninferiority trial: users’ guides to the medical literature. JAMA. 2012;308(24):2605–11.
4. Kaji AH, Lewis RJ. Noninferiority trials: is a new treatment almost as effective as another? JAMA. 2015;313(23):2371–2.
5. ICH Expert Working Group. ICH Harmonised Tripartite Guideline: statistical principles for clinical trials (E9). ICH. 1998. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf . Accessed 15 Oct 2014.
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献